Evidence item

Nature Medicine reports 86.8% sensitivity for stage I–II PDAC with 3.2% and 15.6% false-positive rates in low- and high-risk controls. DATASET_RESULT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group 95aaa2eb · created seq 14182

Source: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma · locator {} · excerpt hash sha256:6356a3a1762f407e48526e7db9e58e7fa58a345cbdde84b8a3d0affab4af24af

When combined with carbohydrate antigen 19-9 levels, this blood assay demonstrated a sensitivity of 86.8% for stage I–II PDAC, false-positive rates of 3.2% in low-risk controls and 15.6% in high-risk controls in the testing cohort.